Kimberly Fleming

Kimberly Fleming, MMA, serves as Director of US Elrexfio Account Marketing and Director of US Market Access Marketing, Oncology at Pfizer since June 2021, focusing on various cancers including Renal Cell Carcinoma and Non Small Cell Lung Cancer. Prior to this role, Kimberly held multiple director positions at EMD Serono, Inc. from October 2001 to June 2021, including Director of Oncology Payer Strategy Marketing and Director of Market Access Channel Strategies Marketing, with a strong emphasis on Trade, Distribution, and Brand Protection. Kimberly earned a Bachelor of Science in Business, Management, Marketing and a Master's degree in Marketing Analytics and Insights from Penn State University.